• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Neuronetics, Inc. - Common Stock (NQ: STIM )

    1.480 +0.060 (+4.23%)
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 27, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Neuronetics, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 Next >
    Earnings Scheduled For March 8, 2022
    Companies Reporting Before The Bell • Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million. •... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Monday
    During Monday's session, 291 companies made new 52-week lows. Also check out this: Insiders Buying These 4 Penny Stocks Noteable 52-Week Lows And Highs: SAP (... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
    On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
    During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low. 
    Via Benzinga
    Executives Buy Around $1M Of 4 Penny Stocks
    The ISM services PMI rose to 58.3 in March from 56.5 in the previous month. Investors, meanwhile, focused on some notable insider trades. 
    Via Benzinga
    Insiders Buying These 4 Penny Stocks
    The Nasdaq Composite gained around 60 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern... 
    Via Benzinga
    Neuronetics's Return On Capital Employed Insights
    According to data from Benzinga Pro, during Q4, Neuronetics's (NASDAQ:STIM) reported sales totaled $15.02 million. Despite a 6.32% increase in earnings, the company posted a loss... 
    Via Benzinga
    Neuronetics Posts Better Than Expected Q4 Results Despite Lower NeuroStar Therapy System Sales
    Neuronetics Inc (NASDAQ: STIM) reported Q4 FY21 sales of $15.02 million, down 4% Y/Y, exceeding previously issued guidance of $13.0 million - $14.0 million and the... 
    Via Benzinga
    The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout
    Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative... 
    Via Benzinga
    Recap: Neuronetics Q4 Earnings
    Neuronetics (NASDAQ:STIM) reported its Q4 earnings results on Tuesday, March 8, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings... 
    Via Benzinga
    Preview: Neuronetics's Earnings
    Neuronetics (NASDAQ:STIM) is set to give its latest quarterly earnings report on Tuesday, 2022-03-08. Here's what investors need to know before the announcement. Analysts estimate... 
    Via Benzinga
    The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
    Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (... 
    Via Benzinga
    Stay Away From Southeast Asian Loyalty Play Society Pass
    Society Pass CEO Dennis Nguyen has big dreams but his company did less than $100k in sales during the quarter before SOPA stock went public. 
    Via InvestorPlace
    Stocks That Hit 52-Week Lows On Friday
    On Friday, 313 companies hit new 52-week lows. Things to Consider About Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
    Tuesday's session saw 109 companies set new 52-week lows. Interesting Points From Today's 52-Week Highs And Lows: The largest company in terms of market cap... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
    Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana (NYSE:HUM) was the biggest company on a market cap... 
    Via Benzinga
    5 Penny Stocks Insiders Are Buying
    When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider... 
    Via Benzinga
    Neuronetics, Inc. (STIM) Q3 2021 Earnings Call Transcript
    STIM earnings call for the period ending September 30, 2021. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    Artificial Intelligence Could Be About To Replace Your Doctor
    FN Media Group Presents GlobalInvestmentDaily.com Market Commentary London – November 2, 2021 – The US health and medical insurance industry is a $1.1-trillion maze that is impossible to navigate. And... 
    Via FinancialNewsMedia
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    A.I. Breakthrough Could Disrupt the $11 Trillion Medical Sector
    FN Media Group Presents Oilprice.com Market Commentary London – October 18, 2021 – A massive disruption now appears imminent in one of the world’s largest – and most important – industries. In much the... 
    Via FinancialNewsMedia
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    The Law Offices of Frank R. Cruz Announces Investigation of Neuronetics, Inc. (STIM) on Behalf of Investors
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    50 Biggest Movers From Yesterday
    Gainers Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares surged 105.1% to close at $14.79 on Wednesday after Oppenheimer initiated coverage on the stock with an Outperform rating... 
    Via Benzinga
    Mid-Afternoon Market Update: Nasdaq Jumps 100 Points; Jasper Therapeutics Shares Spike Higher
    Toward the end of trading Wednesday, the Dow traded up 0.06% to 34,398.86 while the NASDAQ rose 0.70% to 14,566.72. The S&P also rose, gaining 0.31% to 4,364.35. The U.S. has... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Gainers Statera BioPharma (NASDAQ:STAB) shares increased by 16.92% to $3.16 during Wednesday's regular session. The market value of their outstanding shares is at $87.... 
    Via Benzinga
    Mid-Day Market Update: Gold Surges 2%; Neuronetics Shares Plunge
    Midway through trading Wednesday, the Dow traded down 0.43% to 34,229.72 while the NASDAQ rose 0.40% to 14,524.02. The S&P also fell, dropping 0.10% to 4,346.21. The U.S. has... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    40 Stocks Moving In Wednesday's Mid-Day Session
    Gainers Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares jumped 113% to $15.36 after Oppenheimer initiated coverage on the stock with an Outperform rating and a $21 price target... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2021
    Upgrades DA Davidson upgraded the previous rating for Columbia Banking System Inc (NASDAQ: 
    Via Benzinga
    Mid-Morning Market Update: Markets Mixed; JPMorgan Posts Upbeat Earnings
    Following the market opening Wednesday, the Dow traded down 0.36% to 34,254.62 while the NASDAQ rose 0.27% to 14,505.47. The S&P also fell, dropping 0.07% to 4,347.49. The U.S... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Gainers Revance Therapeutics (NASDAQ:RVNC) stock moved upwards by 17.79% to $24.09 during Wednesday's pre-market session. The company's market cap stands at $1.7... 
    Via Benzinga
    The Daily Biotech Pulse: FDA Nod For Lilly, Regulus Slumps On Study Discontinuation, ObSeva Strikes Linzagolix Commercialization Deal
    Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Revance Clarifies Gabellar Line Treatment Review On Track Responding to the... 
    Via Benzinga
    Exposures Product Safety
    < Previous 1 2 3 4 5 6 7 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.